Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
FDA nominee pledges to review cancellation of annual vaccine advisory meeting and to protect advisory committee transparency
Summary
Food and Drug Administration nominee Dr. Marty Makary told the Senate HELP Committee he will reevaluate the decision to cancel the FDA's annual vaccines and related biological products advisory committee meeting and pledged to preserve scientific independence and transparency for advisory panels if confirmed.
Dr. Marty Makary, President Trump's nominee to lead the Food and Drug Administration, told the Senate Committee on Health, Education, Labor, and Pensions that he would review and, if necessary, reconvene the agency's vaccine advisory committee after the committee canceled its annual meeting to recommend influenza vaccine strains.
"You have my commitment to take a look at it," Dr. Makary said when pressed about the Food and Drug Administration's decision to cancel the Vaccines and Related Biological Products Advisory Committee…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
